LDL receptor class A and EGF domain monomers and multimers

Details for Australian Patent Application No. 2004284090 (hide)

Owner Avida, Inc.

Inventors Stemmer, Willem P. C.; Kolkman, Joost A.

Agent Shelston IP

Pub. Number AU-A-2004284090

PCT Pub. Number WO2005/040229

Priority 60/514,391 24.10.03 US

Filing date 22 October 2004

Wipo publication date 6 May 2005

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/040229 Priority application(s): WO2005/040229

17 April 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Avida, Inc., Application No. 2004284090, Under INID (71), correct the name to Avidia, Inc.

26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004284091-Dicationic triaryl analogs as antiprotozoan agents

2004284089-Novel keto-oxadiazole derivatives as cathepsin inhibitors